The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.
"Now, this is something we are still gaining data on, but most recent data looking at convalescent sera of Covid-19 cases in people who received Covaxin, it was found to neutralise the 617 variant," Fauci was quoted as saying during the White House press briefing
This message was conveyed to Chief Secretary Somesh Kumar who held a meeting with Dr. Krishna Ella, MD, Bharat Biotech on Tuesday at BRKR Bhavan following directions from Chief Minister K. Chandrashekar Rao.
Amaravati: The Andhra Pradesh government on Saturday placed an order for purchase of 4.08 crore doses each of Covaxin and Covishield for vaccinating 2.04 crore people in the 18-45 age group from May 1. Government Principal Secretary (Covid Management and Vaccination) Muddada Ravichandra wrote letters to Bharat Biotech MD Krishna Yella and Serum Institute of […]
Safety and efficacy results from the final analysis will be available in June and the final report will be submitted to a peer-reviewed publication, says Bharat Biotech
Hyderabad-based vaccine maker implements expansion across multiple facilities in Hyderabad and Bengaluru to reach about 700 million doses per year capacity
The officials confirmed that the vaccines reportedly went missing on Tuesday, while the case was registered under Section 380 of the Indian Penal Code on Wednesday